Mitochondria mediate dual metabolic and Ca2+ shuttling activities. While the former is required for Ca2+ signalling linked to insulin secretion, the role of the latter in β cell function has not been well understood, primarily because the molecular identity of the mitochondrial Ca2+ transporters were elusive and the selectivity of their inhibitors was questionable. This study focuses on NCLX, the recently discovered mitochondrial Na+/Ca2+ exchanger that is linked to Ca2+ signalling in MIN6 and primary β cells. Suppression either of NCLX expression, using a siRNA construct (siNCLX) or of its activity, by a dominant negative construct (dnNCLX), enhanced mitochondrial Ca2+ influx and blocked efflux induced by glucose or by cell depolarization. In addition, NCLX regulated basal, but not glucose-dependent changes, in metabolic rate, mitochondrial membrane potential and mitochondrial resting Ca2+. Importantly, NCLX controlled the rate and amplitude of cytosolic Ca2+ changes induced by depolarization or high glucose, indicating that NCLX is a critical and rate limiting component in the cross talk between mitochondrial and plasma membrane Ca2+ signalling. Finally, knockdown of NCLX expression was followed by a delay in glucose-dependent insulin secretion. These findings suggest that the mitochondrial Na+/Ca2+ exchanger, NCLX, shapes glucose-dependent mitochondrial and cytosolic Ca2+ signals thereby regulating the temporal pattern of insulin secretion in β cells.
Citation: Nita II, Hershfinkel M, Fishman D, Ozeri E, Rutter GA, Sensi SL, et al. (2012) The Mitochondrial Na+/Ca2+ Exchanger Upregulates Glucose Dependent Ca2+ Signalling Linked to Insulin Secretion. PLoS ONE 7(10): e46649. doi:10.1371/journal.pone.0046649
Editor: Valdur Saks, Université Joseph Fourier, France
Received: June 18, 2012; Accepted: September 3, 2012; Published: October 8, 2012
Copyright: © Nita et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Israeli USA binational grant (BSF) grant 2009344 to DK and IS, Israeli Science Foundation grant (ISF) 985/05 and the German Israeli Foundation (GIF) grants to IS and the Wellcome Trust (Programme Grant 081958/Z/07/Z), DiabetesUK and the Royal Society (Wolfson Research Merit Award) to GAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Cross talk between the plasma membrane and mitochondria is essential for mediating glucose-dependent insulin secretion. Cellular uptake and metabolism of glucose by pancreatic β cells stimulates ATP production , . The subsequent rise of cytosolic ATP initiates cellular depolarization by inhibition of ATP-sensitive K+ channels, opens L-type Ca2+ channels (LTCC), induces a rise in cytosolic Ca2+ and leads to insulin secretion .
Mitochondria however, are also a major hub for cellular Ca2+ transport that is powered by their steep membrane potential. Cytosolic increase in Ca2+ is followed by Ca2+ influx into the mitochondria via the mitochondrial uniporter recently shown to be linked to MCU (mitochondrial Ca2+ uniporter) , . In the mitochondrial matrix, Ca2+ is buffered by calcium phosphate and subsequently extruded by an electrogenic 3Na+/Ca2+ exchanger that uses the mitochondrial membrane potential and Na+ gradient to pump Ca2+ out of the mitochondria back into the cytoplasm . The mitochondrial Ca2+ shuttling has several roles: first, Ca2+ activates at least three key intra-mitochondrial dehydrogenases ,  and hence, serves as a key regulator of the rate of ATP synthesis. Second, the mitochondria are a major and highly dynamic Ca2+ store and the Ca2+ efflux by the mitochondrial exchanger can control the amplitude and duration of cytosolic Ca2+ transients, for example, in neurons  and chromaffin cells . Active influx and Na+ dependent efflux of Ca2+ has been described also in isolated mitochondria from β cells . However, the role of mitochondrial Ca2+ shuttling, and in particular, the mitochondrial Na+/Ca2+ exchanger in glucose dependent Ca2+ signalling in β cells are not well understood. A major complication is that the molecular identity of the mitochondrial Na+/Ca2+ exchanger has been elusive until recently and the concern that the inhibitor of the exchanger, CGP-37157 may interact with other major Ca2+ transport pathways in β cells. For example, CGP-37157 was suggested to trigger mitochondrial Ca2+ rise by blocking the exchanger thereby leading to enhanced mitochondrial oxidative metabolism and insulin secretion . However a subsequent study , suggested that CGP-37157 also affects cytosolic Ca2+ signals by blocking the LTCC in β cells . Other studies further indicated that CGP-37157, like other benzothiazepin compounds, may also modulate the activity of other major Ca2+ transporters among them: sarcoma(-endo) plasmic reticulum Ca2+-ATPase, SERCA, and ryanodine receptors, RyR .
We and subsequently others, found that the Na+/Ca2+ exchanger super family member NCLX is localized in the mitochondria where it mediates Ca2+ efflux and is therefore likely the mitochondrial Na+/Ca2+ exchanger , . We further showed that expression of NCLX is effectively attenuated by small interfering RNA construct and its activity blocked by a catalytic inactive NCLX (dnNCLX) that induce a strong dominant negative effect on the endogenous exchanger activity . Using these molecular tools, siNCLX and dnNCLX, derived from the cloning of NCLX, we sought to determine in the present study the general role of NCLX in shaping cytosolic and mitochondrial Ca2+ signalling linked to insulin secretion. Our results indicate that NCLX is not only critical for mitochondrial Ca2+ efflux but also affects cytoplasmic Ca2+ responses. A major conclusion of this study is that mitochondrial Ca2+ shuttling, catalyzed by NCLX, plays a dominant role in shaping glucose-dependent cytosolic Ca2+ transients and thereby regulates the temporal pattern of insulin secretion.
Six-eight week old female DBA/2J mice were purchased from Jackson laboratories, Bar Harbor, ME, USA. Mice were kept in a pathogen-free environment at the Ben-Gurion University of the Negev Research Animal Facility and were cared for according to the Ben-Gurion University of the Negev Care and Use of Animals committee guidelines.
Animals were anesthetized prior to islet harvest by standard ketamine/xylazine and islets were isolated by collagenase digestion . Briefly, digested pancreata were filtered through 1000 µm and 500 µm sieves and then hand-picked under a stereoscope as previously described .
Cell culture and transfection
Isolated islets were cultured in RPMI 1640 (Beit Haemek, 01-100 1A, Israel) for 2–3 days and MIN6 cells in DMEM (Beit Haemek, 01-055-1A). Both media were supplemented with 10% fetal calf serum (Beit Haemek, 04-001-1A), 1% Pencillin/Streptomycin (Beit Haemek, 02-020-1B), 1% L-Glutamine (Beit Haemek, 03-020-1B), 5 mM Glucose (Gerbu, 2028). Islets were hand-picked under a stereoscope and dispersed into single cells by Trypsin-EDTA (Beit Haemek, 03-053-1B). Dispersed primary islet cells and MIN6 cells were seeded onto coverslips for imaging experiments . Pancreatic β cells were identified in primary islets using anti-human/bovine/mouse insulin monoclonal antibody. Immunohistochemical analysis of insulin were performed and showed that more than 90% of cells in the culture were β cells as previously described .
Pancreatic primary β cells and MIN6 cells cultured on glass coverslips were transfected with siNCLX vs. siControl using DharmaFECT siRNA Transfection Reagents (Dharmacon, T-2004). siRNA NCLX or siControl was diluted in DharmaFECT siRNA transfection reagent, incubated approximately 20 min at room temperature and then added in the antibiotics free media. The efficiency of transfection was assessed by visualizing Dharmacon siGLO Red (Dharmacon, D-001630-02-05) transfection particles according to the protocol provided by manufacturer. The transfection efficiency, for siNCLX delivery as determined by siGlo fluorescent marker was high, ∼80%. Pancreatic primary β cells and MIN6 cells were co-transfected with a dominant negative active form of NCLX , dnNCLX vs. pcDNA and EYFP using Lipofectamine 2000 (Invitrogen, 11668-019). The constructs dnNCLX or pcDNA, were diluted in Lipofectamine 2000, gently mixed and added to plates of cells containing antibiotics free media. Successfully transfected cells were identified by monitoring EYFP fluorescence. Note that EYFP fluorescence does not interfere with monitoring Fura-2 AM (Teflabs, 0102) fluorescence . Typically, 10% of the pancreatic primary β cells were successfully transfected and used for analysing the effect of dnNCLX consistent with the relatively low transfection efficacy of β primary and cell lines . Because the imaging system allows the selection of single cells sufficient number of cell could be obtained despite the relatively low transfection efficiency. Fluorescent ion measurements were conducted 48 h after transfection. Cell viability was determined by monitoring Trypan Blue staining according to a protocol described elsewhere .
Fluorescent Ca2+ imaging
The imaging system consisted of an Axiovert 100 inverted microscope (Zeiss), Polychrome V monochromator (TILL Photonics, Planegg, Germany) and a SensiCam cooled charge-coupled device (PCO, Kelheim, Germany). Fluorescent images were acquired with Imaging WorkBench 4.0 (Axon Instruments, Foster City, CA). Ca2+ imaging was performed in pancreatic primary β cells and MIN6 cells attached onto coverslips and superfused with Ringer solution containing (in mM): 126 NaCl (Frutarom, 2355534700067), 5.4 KCl (Sigma, P9333), 0.8 MgCl2 (Gerbu, 1722), 20 HEPES (Amresco, 0511), 1.8 CaCl2 (Sigma, C1016), 15 Glucose (Gerbu, 2028), pH adjusted to 7.4 with NaOH (Sigma, S8045) or with high K+ (50 mM) Ringer solution when indicated. In glucose dependent experiments the pancreatic primary β cells or MIN6 cells were pre-washed for 30 min with low glucose (3 mM) Ringer solution followed by high glucose (20 mM) Ringer solution.
Pancreatic primary β cells and MIN6 cells were loaded with Fura 2AM, excited with 340/380 nm wavelength light and imaged using a 510 nm long pass filter . Mitochondrial Ca2+ measurements were performed in pancreatic primary β cells infected with lenti-pericam and in MIN6 cells expressing ratiometric mitochondrial pericam, which is targeted solely to the inner membrane of mitochondria , . The mitochondrial pericam fluorescence in both pancreatic primary islet cells and MIN6 cells was acquired at 430 nm excitation and 550 nm emission as previously described .
Fluorescent imaging of metabolic rate and mitochondrial membrane potential
Mitochondrial membrane potential was monitored in MIN6 cells loaded and superfused with TMRM (Invitrogen, T-668), excited at 545 nm and imaged with a 570 nm emission filter as previously described . NAD(P)H intrinsic fluorescence in pancreatic primary β cells was fluorescently monitored (360 nm excitation and 440 nm emission) in an inverted microscope (see Fluorescent Ca2+ imaging), as previously reported  and calibrated by superfusing the cell with a Ringer solution containing 5 µM FCCP, protonophore carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (Ascent Laboratories, Asc-081) at the end of the experiments .
Cell fractionation and immunoblot analysis
Cell fractionation was performed as previously described . Briefly, MIN6 cells were homogenized using a glass Douncer homogenizer with ice cold isolation buffer containing (in mM): 225 Manitol (Sigma, M4125), 75 Sucrose (Sigma, S7903), 0.5 EDTA (Sigma, E5134), 10 HEPES (Amresco, 0511), pH adjusted to 7.4 with KOH (Sigma, P5958). The lysates were centrifuged at 1500×g for 5 min at 4°C, supernatant was re-suspended in 200 µl of the same buffer and re-centrifuged for 4 min at 12,000×g at 4°C. The pellet, containing the mitochondrial fraction was then diluted with 100 µl cold isolation buffer and used immediately for immunoblot analysis. Protein concentration was determined by a modified Lowry procedure, according to manufacturer's protocol (Bio-Rad). Equal amounts of protein (20 µg) from total fraction and pure mitochondria samples were resolved by SDS-PAGE and transferred onto nitrocellulose membranes. Immunoblot analysis was performed as described previously using antibody generated against NCLX (1∶1000) and against VDAC (1∶1000), diluted into 5% milk (Fluka, 70166) in Tris-buffered saline solution with Tween 20 (Sigma, P1379) .
Real time PCR Analysis
RNA was isolated from pancreatic primary islet cells transfected with either siControl (AACGGCCACUCAACUGUCU) or siNCLX (AACGCGCAUCCAACUGUCU) using TRIZol reagent (Invitrogen, 15596-026) following the manufacturer's instructions. The pancreatic primary islets were homogenized in TRIZol, followed by phase separation with chloroform and centrifuged at 12000×g for 15 min at 2°C. RNA was then precipitated from the aqueous phase by mixing with an equal volume of isopropyl alcohol and centrifuged at 12000×g for 10 min at 2°C. Finally, the RNA pellet was dried and dissolved in RNA-ase free water. The cDNA was generated using First Strand cDNA Synthesis Kit (Fermentas, K1611). Thermal cycling (40 cycles) conditions were 50°C for 15 min, followed by 95°C for 15 min, 95°C for 15 sec and 60°C for 60 sec. As reference gene, we employed glyceraldehyde 3-phosphate dehydrogenase (GAPDH). PCR reactions were conducted using a SDS7500 Real Time PCR machine and TaqMan probes (ThermoScientific).
Cellular ATP content
Pancreatic primary islets cells were kept in low glucose (3 mM) Ringer solution for 30 min that was then replaced with high glucose (20 mM) containing Ringer solution. Cells were lysed at the indicated time intervals and ATP content was determined using the luciferin/luciferase luminescence assay with Bioluminescent Cell Titer-Glo Assay Kit (Promega, G7570) according to the manufacturer's instructions.
Insulin secretion was monitored using a commercial ELISA kit (Mercordia, 10-1247-01). Pancreatic islet cells were incubated for 30 min in low glucose (3 mM) Ringer solution and then stimulated with high glucose (20 mM) Ringer solution. Aliquots were collected at the indicated time intervals and the amount of insulin secreted from pancreatic primary islet cells was determined according to the manufacturer's protocol (Mercordia mouse insulin ELISA kit).
The traces of all fluorescent imaging experiments were plotted using KaleidaGraph 4.0. Influx of Ca2+ into the cytosol or mitochondria consistently began after stimulation of pancreatic β cells with High K+, ATP or high glucose. Similarly, Ca2+ efflux out of the mitochondria followed the influx phase as previously described . The fluorescent ratio signals were normalized to the average signal obtained at the beginning of the measurements. The influx and efflux rates were calculated as slope of the linear fit of the fluorescence change during 30 seconds following the given stimulation (i.e. High K+, ATP or high glucose) for Ca2+ influx or Ca2+ efflux as previously described . Peak amplitude was defined according to established protocols , comparing the maximal peak height of the signal to the background fluorescence. Changes in rate of the fluorescence Ca2+ response or their amplitude (ΔCa2+ cytosolic rates or peak amplitude) were calculated by averaging either rates of fluorescence Ca2+ change or the amplitude of the fluorescence Ca2+ response of number of experiments, n, indicated at the figure legends , .
The results of the experiments are the mean ± S.E.M. (standard error of the mean) of at least 3 independent experiments (n), using 20–30 cells in each. Statistical significance for all experiments was determined using a one-way ANOVA test followed by Bonfferoni post-hoc analysis. * Significantly different (P<0.05) compared to control.
The role of NCLX in mitochondrial Ca2+ transport in β cells
We first asked if NCLX is expressed in β cells and if it is participating in mitochondrial Ca2+ transport. Immunoblot analysis of NCLX in total lysates and isolated mitochondria from MIN6 cells demonstrated that NCLX was enriched in mitochondrial fractions (Fig. 1A), a finding consistent with its primary localization in mitochondria . To further determine if the immunoblot signal is related to NCLX, MIN6 cells were transfected with siNCLX vs. siControl constructs (Fig. 1B). Transfection with siNCLX was followed by a marked decrease in NCLX expression suggesting the ∼50 KDa polypeptide is related to NCLX  and indicating that NCLX expression can be molecular controlled.
A. Immunoblot analysis of NCLX expression in total lysate and isolated mitochondria in MIN6 cells (20 µg). B. Immunoblot analysis of NCLX expression in siNCLX vs. siControl (20 µg) transfected MIN6 cell lysates. VDAC and β Actin were used as mitochondrial and cytosolic markers, respectively. C. Knock down of NCLX expression increases Ca2+ influx and inhibits mitochondrial Ca2+ efflux. At the indicated time, cells were superfused with high K+ Ringer solution while monitoring mitochondrial Ca2+ in MIN6 cells transfected with mito-pericam and either siNCLX or siControl. D. Dominant negative NCLX construct increases Ca2+ influx and inhibits mitochondrial Ca2+ efflux. Representative fluorescent traces of pancreatic MIN6 cells co-transfected with mito-pericam and either dnNCLX or control vector (pcDNA), while applying the same experimental paradigm described in Fig. 1C. Insert. Representative images of MIN6 cells co-transfected with mito-pericam. The scale bar is 10 µm. E. Averaged rates of mitochondrial Ca2+ influx of Fig. 1C, D, n = 9 (*P<0.05). F. Averaged rates of mitochondrial Ca2+ efflux of Fig. 1C, D, n = 9 (*P<0.05). G. Silencing of NCLX expression inhibits mitochondrial Ca2+ efflux following a metabotropic cytosolic Ca2+ response. Cells were co-transfected with mito-pericam and either siNCLX or siControl and superfused with Ca2+ free Ringer solution containing 50 µM ATP, while monitoring the Ca2+ response. H. Averaged rates of mitochondrial Ca2+ influx of Fig. 1G, n = 7 (*P<0.05). I. Averaged rates of mitochondrial Ca2+ efflux of Fig. 1G, n = 7 (*P<0.05).
To determine whether NCLX mediates mitochondrial Ca2+ efflux or affecting influx during trans-mitochondrial Ca2+ transport, mitochondrial Ca2+ transport was determined in MIN6 cells co-transfected with the mitochondrial targeted Ca2+ sensor mito-pericam and with either siNCLX or siControl. Following depolarization of the cells with a high K+ (50 mM) Ringer's solution, mitochondrial Ca2+ influx was observed in the siControl cells and was followed by a robust efflux phase. In contrast, in cells transfected with siNCLX the mitochondrial Ca2+ influx rate increased by 50±11% and a dramatic 80±13% reduction of mitochondrial Ca2+ efflux was measured (Fig. 1C, E, F). To determine if this effect is directly linked to NCLX activity, we compared mitochondrial Ca2+ transport in cells co-transfected with mito-pericam and either the dominant negative dnNCLX or a control vector pcDNA. We again monitored an increase of mitochondrial Ca2+ influx rate (200±5%) and a decrease in efflux (65±4%) in the cells transfected with the dnNCLX construct (Fig. 1D, E, F).
In an additional set of experiments, we monitored the mitochondrial Ca2+ response following a metabotropic stimulus triggered by ATP in cells superfused with Ca2+-free Ringer solution (Fig. 1G). The mitochondrial Ca2+ influx rate following of ATP increased by 40±5% and the efflux was reduced by 50±7% during this metabotropic response (Fig. 1H, I).
Altogether, the results of this set of experiments indicate that NCLX is located in the mitochondria of β cells and participates in trans-mitochondrial Ca2+ shuttling by affecting primarily the Ca2+ efflux but notably also the influx phase following cellular Ca2+ influx or release from ER/Ca2+ stores.
Considering the major effect of NCLX on mitochondrial Ca2+ transients, we next sought to determine the role of NCLX on mitochondrial Ca2+ responses triggered by high glucose. We further asked if NCLX regulates the mitochondrial membrane potential and resting Ca2+ level. Mitochondrial Ca2+ was monitored in MIN6 cells that were initially superfused with low glucose (3 mM) followed by application of high glucose (20 mM) Ringer solution. Application of high glucose triggered a robust mitochondrial Ca2+ transient (Fig. 2A). Knockdown of NCLX expression was followed by an increase in Ca2+ influx (50±4%) and a decrease of Ca2+ efflux (56±7%) (Fig. 2B, C). To determine the effect of NCLX on mitochondrial membrane potential, we applied the same experimental paradigm using cells loaded with the mitochondrial membrane potential dye TMRM (0.05 µM). Addition of high glucose was followed consistently with previous studies  by small hyperpolarisation of the mitochondria that was unaffected by silencing of NCLX (Fig. 2D). Comparison of the resting mitochondrial membrane potential in siNCLX vs. siControl was performed by comparing the mitochondrial membrane potential before and after the application of FCCP. This analysis indicated however that knocking down NCLX expression led to a small and tonic mitochondrial depolarization (Fig. 2D). We next asked if expression of NCLX is linked to mitochondrial resting Ca2+ concentration by comparing basal mito-pericam fluorescence values of siControl vs. siNCLX transfected cells . As shown in Fig. 2E, knockdown of NCLX expression was followed by a minor, but significant increase in resting mitochondrial Ca2+ levels. No difference in overall number and cells stained by Trypan Blue was observed between siNCLX vs. siControl indicating that NCLX does not affect the viability of β cells (results not shown).
A. Silencing of NCLX expression blocks the glucose dependent mitochondrial Ca2+ efflux. The mitochondrial Ca2+ transport was monitored in MIN6 cells co-transfected with mito-pericam and either siNCLX or siControl. Cells were first superfused with low glucose (3 mM) Ringer followed by high glucose (20 mM) Ringer solution. B. Averaged rates of mitochondrial Ca2+ influx of Fig. 2A, n = 11 (*P<0.05). C. Averaged rates of mitochondrial Ca2+ efflux of Fig. 2A, n = 11 (*P<0.05). D. Silencing NCLX modulates the basal but not glucose dependent change in mitochondrial membrane potential. Changes in mitochondrial membrane potential were monitored in MIN6 cells transfected with siNCLX or siControl, superfused continuously with 0.05 µM TMRM. FCCP 5 µM was added in the indicated times to calibrate the signal. E. Effect of knock down of NCLX expression on mitochondrial resting Ca2+ in MIN6 cells transfected with siNCLX vs. siControl. Averaged mitochondrial Ca2+ basal signals, n = 10 (*P<0.05).
Altogether, the results of this part indicate that NCLX participates in glucose-dependent mitochondrial Ca2+ efflux and also regulates the rate of Ca2+ influx transient. Notably, we find that NCLX controls mitochondrial properties, also under resting conditions as the knockdown of NCLX is followed by a mild mitochondrial depolarization and a rise in resting mitochondrial Ca2+.
The role of mitochondrial NCLX in cytosolic calcium changes
Ionotropic Ca2+ influx is a major step in initiating the secretory process in β cells. We have therefore sought to determine the role of NCLX in regulating this process. Cytosolic Ca2+ entry was initially triggered in pancreatic MIN6 cells by depolarization with high K+ (50 mM) Ringer while monitoring Fura 2 AM fluorescence. We then asked if knockdown of NCLX expression will modulate cytosolic Ca2+ signals. Comparison of cytosolic Ca2+ rise of siNCLX vs. siControl transfected MIN6 cells showed a marked decrease in the rate of cytosolic Ca2+ changes of 45±10% and a decrease of 10±5% in the amplitude of the cytosolic Ca2+ signals transfected with siNCLX (Fig. 3A, C, E). We then asked if reducing NCLX activity will also modulate the cytosolic Ca2+ signals. The same paradigm was applied to MIN6 cells transfected with either the dominant negative construct of NCLX, dnNCLX, or pcDNA (Fig. 3B) . Similarly to the knocking down of NCLX expression, dnNCLX decreased the rate of cytosolic Ca2+ changes and amplitude by 48±10% and 10±5% respectively (Fig. 3B, D, F).
A. Silencing of NCLX expression inhibits cytosolic Ca2+ responses. MIN6 cells either transfected with siNCLX or siControl were loaded with Fura 2 AM and depolarized with high K+ Ringer solution, while monitoring cytosolic Ca2+ responses. B. Dominant negative mutant NCLX, dnNCLX inhibits cytosolic Ca2+ responses. MIN6 cells transfected with either dnNCLX or control vector (pcDNA) were loaded with Fura 2 AM and cytosolic Ca2+ was monitored as described in Fig. 3A. C. Averaged rates of cytosolic Ca2+ responses of Fig. 3A, n = 12 (*P<0.05). D. Averaged rates of cytosolic Ca2+ responses of Fig. 3B, n = 12 (*P<0.05). E. Averaged cytosolic Ca2+ response amplitude of Fig. 3A, n = 12 (*P<0.05). F. Averaged cytosolic Ca2+ response amplitude of Fig. 3B, n = 12 (*P<0.05).
Thus, the results of this set of experiments indicate that NCLX activity plays a major role in controlling both the rate and amplitude of cytosolic Ca2+ responses.
The role of mitochondrial NCLX in glucose-induced cytosolic calcium signals
The above results identified NCLX as the mitochondrial exchanger in β cells and highlight its role in mediating the cross talk with plasma membrane Ca2+ influx pathways. The physiological stimulus linked to insulin secretion is however mediated by glucose. Further although MIN6 are a well-established model for β cells, the primary β cells manifest a clearer link between glucose, Ca2+ signalling and insulin secretion . We therefore next sought to determine the role of NCLX in shaping cytosolic Ca2+ transients triggered by glucose by controlling the expression of NCLX using siNCLX in primary β cells.
Efficacy of siNCLX delivery in primary β cells was determined by co-transfection with siGlo fluorescent marker (see Methods), which indicated that the siGLO constructs were taken up by at least 80% of the cells. Consistent with this high transfection rate, efficacy of NCLX knockdowns determined by real-time PCR analysis (Fig. 4A), showed at least a 10 fold reduction in mRNA NCLX in cells transfected with siNCLX. As expected, application of high glucose triggered an increase in the cytosolic Ca2+ response in control cells (Fig. 4B). Remarkably, a 43±15% (Fig. 4B, D, F) reduction in the rate of cytosolic Ca2+ changes as well as a decrease of 40±5% of the amplitude of Ca2+ signals in cells transfected with the siNCLX was observed, indicating the importance of the mitochondrial exchanger, NCLX, for enhancing the rise of glucose-dependent cytosolic Ca2+. The knock down of NCLX activity using dnNCLX (Fig. 4C) led to a similar reduction both in the rates of cytosolic Ca2+ changes by 35±17%, and in the amplitude of Ca2+ signals by 30±8% (Fig. 4C, E, G).
A. Real time PCR analysis of mRNA NCLX expression normalized to GAPDH in pancreatic primary β cells transfected with siNCLX vs. siControl, n = 3 (*P<0.05). B. Silencing NCLX expression inhibits glucose-induced Ca2+ entry in primary β cells. Representative fluorescent traces of cytosolic Ca2+ in pancreatic primary β cells transfected with either siNCLX or siControl loaded with Fura 2 AM and stimulated with high glucose following the same experimental paradigm described in Fig. 2A. Insert. Shows representative images of MIN6 cells co-transfected with the Dharmacon siGLO Red transfection reagent. The scale bar is 10 µm. C. NCLX dominant negative construct inhibits glucose dependent cytosolic Ca2+ changes in primary β cells. Representative fluorescent traces of primary β cells transfected with dnNCLX or control vector (pcDNA) loaded with Fura 2 AM and treated with high glucose when indicated. D. Averaged rates of cytosolic Ca2+ responses of Fig. 4B, n = 10 (*P<0.05). E. Averaged rates of cytosolic Ca2+ responses of Fig. 4C, n = 10 (*P<0.05). F. Averaged cytosolic Ca2+ amplitudes of Fig. 4B, n = 10 (*P<0.05). G. Averaged cytosolic Ca2+ amplitudes of Fig. 4C, n = 10 (*P<0.05).
Hence, this set of experiments indicates that NCLX shapes the rate and amplitude of glucose-dependent cytosolic Ca2+ responses in primary β cells.
The role of mitochondrial NCLX in glucose dependent mitochondrial calcium homeostasis
We next sought to determine if NCLX determines the trans-mitochondrial Ca2+ transient and metabolic rate manifested by the ratio of NAD(P)H/NAD+. The mitochondrial Ca2+ transient signal was monitored in primary β cells co-transfected with a lenti viral construct of mito-pericam (Fig. 5A), following the same experimental procedure described in Fig. 4B. The mitochondrial rate of Ca2+ uptake was increased by 50±15% and the Ca2+ efflux rates were strongly reduced by 70±7% (Fig. 5B, C) in pancreatic primary β cells transfected with siNCLX compared to the rates measured in siControl transfected cells.
A. Knocked down of NCLX modulates mitochondrial calcium transport. Pancreatic primary β cells were infected with lenti-pericam viral particles and transfected with either siNCLX or siControl and superfused with the indicated high glucose Ringer solution. Insert. Representative image of pancreatic primary β cell infected with lenti-pericam. The scale bar is 10 µm. B. Averaged mitochondrial Ca2+ influx rates of pancreatic primary β cells of Fig. 5A, n = 3 (*P<0.05). C. Averaged mitochondrial Ca2+ efflux rates of Fig. 5A, n = 3 (*P<0.05). D. Effect of NCLX on respiratory chain activity determined by monitoring NAD(P)H intrinsic fluorescence in pancreatic primary β cells, transfected with either siNCLX or siControl before and after application of high glucose Ringer solution. FCCP or high glucose Ringer's solution was added where indicated.
We then determined the effect of NCLX expression on the ratio of NAD(P)H/NAD+ by measuring NADH autofluorescence. Consistent with previous studies , addition of high glucose Ringer's solution was followed by enhanced NAD(P)H production. Silencing NCLX expression did not affect the stimulatory effect of high glucose on NAD(P)H (Fig. 5D). However, determination of NAD(P)H/NAD+ fluorescence following addition of the FCCP indicated that the basal metabolic rate in cells transfected with siNCLX was enhanced (Fig. 5D) suggesting that the slightly elevated resting mitochondrial Ca2+ triggered by the knock down of NCLX expression (Fig. 5A) was sufficient to enhance basal NAD(P)H/NAD+ ratio.
Altogether, the results of this part suggest that NCLX is regulating the rates and amplitude of influx and efflux phases of mitochondrial Ca2+ transients induced by high glucose and it is also affecting the basal NAD(P)H production rates.
The link between NCLX, glucose-dependent ATP production and insulin secretion
We next determined the time course of glucose-dependent ATP production by monitoring luciferase luminescence in primary β cells lysates . In general, rate of glucose-dependent ATP production was not affected by NCLX expression; it was however transiently reduced at 1 min by 37±0.5% following glucose application in the NCLX knock down cells compared to control (Fig. 6A).
A. Effect of NCLX silencing expression on ATP production. The ATP content was determined in pancreatic primary β cells lysates transfected with either siNCLX or siControl and stimulated with high glucose in the indicated times (see Experimental Procedures), n = 3 (*P<0.05). B. Effect of NCLX knocked down expression on glucose dependent insulin secretion. Cultured pancreatic primary β cells were transfected with either siNCLX or siControl and amounts of secreted insulin were determined in the indicated times, n = 3 (*P<0.05).
Finally, considering the major role of NCLX on glucose-dependent cytosolic Ca2+ response, we asked if it also participates in regulating the rate of insulin secretion. We used primary β cells transfected with siNCLX vs. siControl while monitoring insulin secretion before and after application of high glucose Ringer's solution. The supernatant of treated cells was collected at the indicated time intervals and amounts of secreted insulin levels were determined. Partial inhibition by 40±8% - 1 min, 40±14% - 2 min, 60±16% – 5 min, in the rate of insulin secretion was monitored in siNCLX primary β cells during the first 5 minutes (Fig. 6B). This trend was however reversed and amounts of secreted insulin were similar at latter time points following application of glucose in siNCLX vs. siControl treated primary β cells.
Thus, our results indicate that NCLX has a small effect on high glucose dependent ATP production, but primarily regulates rates of glucose-dependent insulin secretion particularly during the first phase of insulin secretion.
The activity of the mitochondrial Na+/Ca2+ exchanger and its role in Ca2+ signalling leading to insulin secretion is of major interest because of the dual role of mitochondrial Ca2+ shuttling on mitochondrial metabolism and on global Ca2+ signalling . The activity of major players in mitochondrial Ca2+ shuttling, the uniporter and exchanger in pancreatic β cells, has been documented in several studies , . However, their role in regulating Ca2+ signals, and subsequent insulin secretion remains controversial because it was unclear whether their inhibitors might modulate non-specifically other Ca2+ transporters , , thus underscoring the importance of a molecular based approach to analyse the role of mitochondria in these processes.
Towards this goal, we first asked if NCLX, recently identified by our group as a candidate for the mitochondrial Na+/Ca2+ exchanger , plays a similar role in pancreatic β cells, and if molecular tools aimed at inhibiting its expression or activity can be used to analyse Ca2+ signalling and secretion in these cells. Our results indicate that NCLX is the mitochondrial exchanger in pancreatic β cells and that its expression or activity can be molecularly targeted based on the following findings: 1) NCLX is localized in the mitochondria of β cells, 2) silencing of NCLX expression leads to inhibition of mitochondrial Ca2+ efflux, 3) transfection of β cells with a dominant negative NCLX construct has a similar inhibitory effect on mitochondrial Ca2+ efflux activity, 4) both knock down of NCLX expression or activity inhibit mitochondrial calcium efflux following a glucose-dependent Ca2+ rise. However, our results indicate that NCLX in β cells has an additional role that has not been documented in previous studies . We show that silencing of NCLX expression or activity also enhances the rate of mitochondrial Ca2+ influx in β cells. This suggests that the Ca2+ efflux mediated by NCLX is strongly activated already at the early phase of mitochondrial Ca2+ influx and thus, NCLX has the capacity to shape not only the mitochondrial Ca2+ efflux phase but also indirectly the Ca2+ rise in this organelle. This effect is particularly remarkable considering that the influx phase, that was previously monitored in many cell types is about 2 orders of magnitude faster than the efflux phase . Consistent with this dominant role of NCLX on the mitochondrial Ca2+ response, we observed that NCLX determines the resting levels of mitochondrial Ca2+ in β cells, a finding that may explain the role of NCLX in metabolic processes (discussed below). These major effects of NCLX are consistent with the high pancreatic expression of NCLX in β cells .
In our recent report  describing the role of the mitochondrial uniporter MCU ,  in single β cells, preliminary observations suggested that silencing of NCLX modulated the amplitude of mitochondrial calcium increase in response to stimulated Ca2+ influx. The effects of NCLX elimination on mitochondrial calcium changes prompted by physiological stimulation with glucose were not explored, nor were the kinetics of mitochondrial transport, mitochondrial membrane potential or glucose-regulated insulin secretion. In the detailed studies described here we now show that NCLX plays a key role in regulating the glucose-dependent Ca2+ response in the cytosol and the mitochondria. Our results indicate that NCLX activity is critical for clearance of mitochondrial Ca2+ and is therefore a rate limiting player in the mitochondrial Ca2+ response induced by glucose. In addition, we demonstrated that by catalysing the mitochondrial efflux, NCLX also shapes the cytosolic glucose-dependent Ca2+ response and thereby, regulates the rate of insulin secretion.
Mitochondria are occupying vastly different relative volumes in different cell types and play a highly heterologous role in regulating cytosolic Ca2+ in distinct tissues. For example, in cardiac tissue they occupy ∼30% of the total volume , but play a relatively minor role in shaping the cytosolic Ca2+ responses . In contrast, in chromaffin cells  the estimated mitochondrial cell occupancy is only about 6%, yet the mitochondria play a major role in cytosolic Ca2+ uptake. The estimated occupancy of mitochondria in β cells is even lower at about 4% , however our findings indicate that despite their relatively modest volume, they are playing a major role in shaping the Ca2+ signalling of β cells. We find that silencing either the expression or the activity of NCLX, decreases the rate of cytosolic Ca2+ changes by glucose by approx. 40% and the amplitude of the Ca2+ signals by 30%. Considering the small volume occupied by the mitochondria and the large change that it triggers in cytosolic Ca2+, our results indicate that it outpaces by several fold, the transport rate mediated by the plasma membrane and ER Ca2+ transporters. Remarkably, despite the major cytosolic Ca2+ changes triggered by NCLX, the mitochondrial changes are relatively modest. Several studies have underscored the powerful Ca2+ buffering capacity of mitochondria, in particular the formation of calcium phosphate, that is at least 10 fold stronger than the buffering capacity of the cytosolic Ca2+ . Furthermore, mitochondrial Ca2+ buffering, dependent on matrix pH, allows a rapid dissociation of Ca2+ phosphate, thus readily providing the exchanger with Ca2+ . Such mechanism can explain how the small changes in mitochondrial Ca2+ provide sufficient amounts of Ca2+ required to change its cytosolic concentrations.
Recent studies have highlighted the physical proximity and functional cross-talk between the L-type calcium channels, LTCC and the mitochondrial network. This leads to a robust LTCC-dependent rise of local Ca2+ in the vicinity of mitochondria followed by enhanced mitochondrial Ca2+ uptake . A rapid uptake by mitochondria may provide a fast Ca2+ clearing mechanism thereby minimizing the potential toxic effect of a strong cytosolic Ca2+ surge. On the other hand, a rapid decline in cytosolic Ca2+ may interfere with the first phase of insulin secretion, which requires a sufficient rise in cytosolic Ca2+ because of the low Ca2+ affinity of the secretory machinery . Previous studies have indeed underscored the requirements for sustained Ca2+ rise during the first phase of insulin secretion . In contrast, the second phase is dominated by the R-Type Ca2+ channels and requires a more moderate Ca2+ rise , . Our results suggest that NCLX is tuning the cytosolic Ca2+ levels in β cells by mediating a continuous and robust mitochondrial Ca2+ efflux, thereby preventing rapid cytosolic Ca2+ decline and augmenting sustained elevated cytosolic Ca2+ levels required for this secretory phase. This role in secretion is supported by our finding demonstrating a delay in glucose-dependent insulin secretion triggered by silencing of NCLX. Thus, we suggest a more dominant role for strong Ca2+ rise during the first phase of insulin secretion. An important finding of this study is that the role of the mitochondrial exchanger NCLX in regulating the cytosolic Ca2+ determines the rate of insulin secretion during the initial phase of secretion. Previous studies using the mitochondrial exchanger inhibitor CGP-37157 suggested that the inhibition of the exchanger led to enhanced ATP production and insulin secretion . In contrast, and consistent with similar observations ,  we find that knock down of NCLX expression does not lead to enhanced glucose-dependent ATP production. This effect may be related to the role of NCLX in shaping the basal mitochondrial resting Ca2+ in β cells. Our results indicate that the silencing of NCLX leads to a small but significant rise in basal mitochondrial resting Ca2+. Because the affinity of the Ca2+ sensitive Kreb's cycle enzymes is relatively high, even such a modest rise in Ca2+ may be already sufficient to induce their activation at low levels of glucose . Indeed, the metabolic pathway is highly sensitive to even small changes in mitochondrial Ca2+. Consistent with such a mechanism, we observed that the acceleration of the basal metabolic rate was induced following knockdown of NCLX expression. In addition, knockdown of NCLX is followed by partial mitochondrial depolarization that may further decrease the efficiency of ATP production. Alternatively, the rise in resting mitochondrial Ca2+ could trigger the formation of oxygen radicals of NO species that may have an inhibitory effect on metabolic processes in β cells . Therefore, an important conclusion of this study is that effects on resting metabolic rate triggered by inactivation of NCLX are likely to play a mitigating role in the potentially stimulatory effect of NCLX knockdown on ATP production during the high glucose phase. Thus, our findings argue against a major energetic role played by the exchanger in Ca2+ signalling linked to insulin secretion as previously suggested based on the inhibition of the exchanger by CGP-37157. The latter effect may have also been related to the modulatory effect of this compound on other major Ca2+ pathways such as the L-type Ca2+ channel or SERCA, that can affect ATP consumption and thereby could indirectly change the energy balance in β cells . Instead, our results indicate that the Ca2+ transport activity mediated by NCLX and its strong effect on increasing cytosolic Ca2+ responses, are the primary roles of NCLX that are linked to insulin secretion. Further in vivo studies, employing for example transgenic NCLX knockout mice, will be required to study the contribution of mitochondrial Ca2+ shuttling on these aspects of islet physiology.
We thank to Dr. Miyawaki A. for the generous gift of mito-pericam. We thank Prof. Ilya Fleidervisch for fruitful discussions. We greatly appreciate the technical support of Sharon Hermann, Hila Asraf and Galit Shahaf.
Conceived and designed the experiments: IN IS MH EL. Performed the experiments: IN DF. Analyzed the data: IN MH GR DK IS. Contributed reagents/materials/analysis tools: EL EO DF. Wrote the paper: IN IS MH GR DK SLS.
- 1. Ashcroft SJ, Weerasinghe LC, Randle PJ (1973) Interrelationship of islet metabolism, adenosine triphosphate content and insulin release. Biochem J 132: 223–231.
- 2. Kennedy HJ, Pouli AE, Ainscow EK, Jouaville LS, Rizzuto R, et al. (1999) Glucose generates sub-plasma membrane ATP microdomains in single islet beta-cells. Potential role for strategically located mitochondria. J Biol Chem 274: 13281–13291.
- 3. Henquin JC (2004) Cellular mechanisms of insulin secretion. Ann Endocrinol (Paris) 65: 8.
- 4. Baughman JM, Perocchi F, Girgis HS, Plovanich M, Belcher-Timme CA, et al. (2011) Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 476: 341–345.
- 5. De Stefani D, Raffaello A, Teardo E, Szabo I, Rizzuto R (2011) A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 476: 336–340.
- 6. Carafoli E, Tiozzo R, Lugli G, Crovetti F, Kratzing C (1974) The release of calcium from heart mitochondria by sodium. J Mol Cell Cardiol 6: 361–371.
- 7. Rutter GA (1990) Ca2(+)-binding to citrate cycle dehydrogenases. Int J Biochem 22: 1081–1088.
- 8. Denton RM, Mccormack JG (1990) Ca-2+ as a 2nd Messenger within Mitochondria of the Heart and Other Tissues. Annual Review of Physiology 52: 451–466.
- 9. White RJ, Reynolds IJ (1997) Mitochondria accumulate Ca2+ following intense glutamate stimulation of cultured rat forebrain neurones. Journal of Physiology-London 498: 31–47.
- 10. Herrington J, Park YB, Babcock DF, Hille B (1996) Dominant role of mitochondria in clearance of large Ca2+ loads from rat adrenal chromaffin cells. Neuron 16: 219–228.
- 11. Prentki M, Janjic D, Wollheim CB (1983) The Regulation of Extra-Mitochondrial Steady-State Free Ca-2+ Concentration by Rat Insulinoma Mitochondria. Journal of Biological Chemistry 258: 7597–7602.
- 12. Lee B, Miles PD, Vargas L, Luan P, Glasco S, et al. (2003) Inhibition of mitochondrial Na+-Ca2+ exchanger increases mitochondrial metabolism and potentiates glucose-stimulated insulin secretion in rat pancreatic islets. Diabetes 52: 965–973.
- 13. Luciani DS, Ao P, Hu X, Warnock GL, Johnson JD (2007) Voltage-gated Ca(2+) influx and insulin secretion in human and mouse beta-cells are impaired by the mitochondrial Na(+)/Ca(2+) exchange inhibitor CGP-37157. Eur J Pharmacol 576: 18–25.
- 14. Thu le T, Ahn JR, Woo SH (2006) Inhibition of L-type Ca2+ channel by mitochondrial Na+-Ca2+ exchange inhibitor CGP-37157 in rat atrial myocytes. Eur J Pharmacol 552: 15–19.
- 15. Neumann JT, Diaz-Sylvester PL, Fleischer S, Copello JA (2011) CGP-37157 inhibits the sarcoplasmic reticulum Ca(2)+ ATPase and activates ryanodine receptor channels in striated muscle. Mol Pharmacol 79: 141–147.
- 16. Palty R, Silverman WF, Hershfinkel M, Caporale T, Sensi SL, et al. (2010) NCLX is an essential component of mitochondrial Na+/Ca2+ exchange. Proc Natl Acad Sci U S A 107: 436–441.
- 17. Kim B, Matsuoka S (2008) Cytoplasmic Na+-dependent modulation of mitochondrial Ca2+ via electrogenic mitochondrial Na+-Ca2+ exchange. J Physiol 586: 1683–1697.
- 18. Lewis EC, Mizrahi M, Toledano M, Defelice N, Wright JL, et al. (2008) alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice. Proc Natl Acad Sci U S A 105: 16236–16241.
- 19. Jonkers FC, Jonas JC, Gilon P, Henquin JC (1999) Influence of cell number on the characteristics and synchrony of Ca2+ oscillations in clusters of mouse pancreatic islet cells. Journal of Physiology-London 520: 839–849.
- 20. Lindskog C, Korsgren O, Ponten F, Eriksson JW, Johansson L, et al. (2012) Novel pancreatic beta cell-specific proteins: antibody-based proteomics for identification of new biomarker candidates. J Proteomics 75: 2611–2620.
- 21. Palty R, Hershfinkel M, Yagev O, Saar D, Barkalifa R, et al. (2006) Single alpha-domain constructs of the Na+/Ca2+ exchanger, NCLX, oligomerize to form a functional exchanger. Biochemistry 45: 11856–11866.
- 22. Ohki EC, Tilkins ML, Ciccarone VC, Price PJ (2001) Improving the transfection efficiency of post-mitotic neurons. Journal of Neuroscience Methods 112: 95–99.
- 23. Scanlon JM, Brocard JB, Stout AK, Reynolds IJ (2000) Pharmacological investigation of mitochondrial ca(2+) transport in central neurons: studies with CGP-37157, an inhibitor of the mitochondrial Na(+)-Ca(2+) exchanger. Cell Calcium 28: 317–327.
- 24. Jonkers FC, Henquin JC (2001) Measurements of cytoplasmic Ca2+ in islet cell clusters show that glucose rapidly recruits beta-cells and gradually increases the individual cell response. Diabetes 50: 540–550.
- 25. Nagai T, Sawano A, Park ES, Miyawaki A (2001) Circularly permuted green fluorescent proteins engineered to sense Ca2+. Proc Natl Acad Sci U S A 98: 3197–3202.
- 26. Robert V, Gurlini P, Tosello V, Nagai T, Miyawaki A, et al. (2001) Beat-to-beat oscillations of mitochondrial [Ca(2+)] in cardiac cells. Embo Journal 20: 4998–5007.
- 27. Brennan JP, Berry RG, Baghai M, Duchen MR, Shattock MJ (2006) FCCP is cardioprotective at concentrations that cause mitochondrial oxidation without detectable depolarisation. Cardiovasc Res 72: 322–330.
- 28. Quesada I, Villalobos C, Nunez L, Chamero P, Alonso MT, et al. (2008) Glucose induces synchronous mitochondrial calcium oscillations in intact pancreatic islets. Cell Calcium 43: 39–47.
- 29. Rocheleau JV, Head WS, Piston DW (2004) Quantitative NAD(P)H/flavoprotein autofluorescence imaging reveals metabolic mechanisms of pancreatic islet pyruvate response. J Biol Chem 279: 31780–31787.
- 30. Paucek P, Jaburek M (2004) Kinetics and ion specificity of Na+/Ca2+ exchange mediated by the reconstituted beef heart mitochondrial Na+/Ca2+ antiporter. Biochimica Et Biophysica Acta-Bioenergetics 1659: 83–91.
- 31. Palty R, Ohana E, Hershfinkel M, Volokita M, Elgazar V, et al. (2004) Lithium-calcium exchange is mediated by a distinct potassium-independent sodium-calcium exchanger. J Biol Chem 279: 25234–25240.
- 32. Akhmedov D, Braun M, Mataki C, Park KS, Pozzan T, et al. (2010) Mitochondrial matrix pH controls oxidative phosphorylation and metabolism-secretion coupling in INS-1E clonal beta cells. FASEB J 24: 4613–4626.
- 33. Akhmedov D, Braun M, Mataki C, Park KS, Pozzan T, et al. (2010) Mitochondrial matrix pH controls oxidative phosphorylation and metabolism-secretion coupling in INS-1E clonal beta cells. Faseb Journal 24: 4613–4626.
- 34. Efrat S (2004) Regulation of insulin secretion: insights from engineered beta-cell lines. Ann N Y Acad Sci 1014: 88–96.
- 35. Luciani DS, Misler S, Polonsky KS (2006) Ca2+ controls slow NAD(P)H oscillations in glucose-stimulated mouse pancreatic islets. J Physiol 572: 379–392.
- 36. Kennedy ED, Wollheim CB (1998) Role of mitochondrial calcium in metabolism-secretion coupling in nutrient-stimulated insulin release. Diabetes Metab 24: 15–24.
- 37. Rossi CS, Vasington FD, Carafoli E (1973) The effect of ruthenium red on the uptake and release of Ca 2+ by mitochondria. Biochem Biophys Res Commun 50: 846–852.
- 38. Carafoli E, Gazzotti P (1973) The reaction of Ca++ with the inner and outer membrane of mitochondria. Experientia 29: 408–409.
- 39. Murgia M, Giorgi C, Pinton P, Rizzuto R (2009) Controlling metabolism and cell death: at the heart of mitochondrial calcium signalling. J Mol Cell Cardiol 46: 781–788.
- 40. Lukyanenko V, Chikando A, Lederer WJ (2009) Mitochondria in cardiomyocyte Ca2+ signaling. Int J Biochem Cell Biol 41: 1957–1971.
- 41. Balaban RS (2009) The role of Ca(2+) signaling in the coordination of mitochondrial ATP production with cardiac work. Biochim Biophys Acta 1787: 1334–1341.
- 42. Rutter GA, Theler JM, Murgia M, Wollheim CB, Pozzan T, et al. (1993) Stimulated Ca2+ influx raises mitochondrial free Ca2+ to supramicromolar levels in a pancreatic beta-cell line. Possible role in glucose and agonist-induced insulin secretion. J Biol Chem 268: 22385–22390.
- 43. Nicholls DG, Chalmers S (2004) The integration of mitochondrial calcium transport and storage. J Bioenerg Biomembr 36: 277–281.
- 44. Szabadkai G, Duchen MR (2008) Mitochondria: the hub of cellular Ca2+ signaling. Physiology (Bethesda) 23: 84–94.
- 45. Giacomello M, Drago I, Bortolozzi M, Scorzeto M, Gianelle A, et al. (2010) Ca2+ Hot Spots on the Mitochondrial Surface Are Generated by Ca2+ Mobilization from Stores, but Not by Activation of Store-Operated Ca2+ Channels. Mol Cell 38: 280–290.
- 46. Barg S, Ma XS, Eliasson L, Galvanovskis J, Gopel SO, et al. (2001) Fast exocytosis with few Ca2+ channels in insulin-secreting mouse pancreatic B cells. Biophys J 81: 3308–3323.
- 47. Pedersen MG, Sherman A (2009) Newcomer insulin secretory granules as a highly calcium-sensitive pool. Proc Natl Acad Sci U S A 106: 7432–7436.
- 48. Jing X, Li DQ, Olofsson CS, Salehi A, Surve VV, et al. (2005) CaV2.3 calcium channels control second-phase insulin release. J Clin Invest 115: 146–154.
- 49. Tarasov AI, Semplici F, Ravier MA, Bellomo EA, Pullen TJ, et al. (2012) The Mitochondrial Ca(2+) Uniporter MCU Is Essential for Glucose-Induced ATP Increases in Pancreatic beta-Cells. PloS One 7: e39722.
- 50. Cardenas C, Miller RA, Smith I, Bui T, Molgo J, et al. (2010) Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell 142: 270–283.
- 51. Jekabsone A, Ivanoviene L, Brown GC, Borutaite V (2003) Nitric oxide and calcium together inactivate mitochondrial complex I and induce cytochrome c release. J Mol Cell Cardiol 35: 803–809.
- 52. Norris SM, Bombardier E, Smith IC, Vigna C, Tupling AR (2010) ATP consumption by sarcoplasmic reticulum Ca2+ pumps accounts for 50% of resting metabolic rate in mouse fast and slow twitch skeletal muscle. Am J Physiol Cell Physiol 298: C521–529.